Randomized trial investigates inflammatory outcomes in models of multiple sclerosis, suggesting potential benefits.
memory B cells in mice. While Phase 3 clinical trial results in MS are awaited, the drug favorably affects inflammatory outcomes in MS models.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: